Summary by Moomoo AI
KEYSTONE PHARMACEUTICAL-B (THE “COMPANY”) ANNOUNCED ON 4 MARCH 2024 THAT, ACCORDING TO PUBLIC INFORMATION ON 16 FEBRUARY 2024, THE COMPANY IS NO LONGER A QUALIFYING SECURITY FOR THE HANG SENG COMPOSITE INDEX AND WILL NOT BE INCLUDED IN HONG KONG SHARES FROM 4 MARCH 2024. After reasonable enquiries, the Company confirms that it is not aware of any other reasons for the changes or inside information to be disclosed other than the above changes. The company emphasizes that business operations and finances remain normal, without significant changes, and the business is basically carried out as planned. Keystone Pharmaceuticals will release its annual results announcement at the end of March and plans to hold an investor briefing following the announcement, at which time further information will be provided on its business operations and financial condition.